Pooled analysis of the BrighTNess, CALGB 40603 (Alliance), and GeparSixto clinical trials identifies the impact of neoadjuvant carboplatin on pCR and survival in earlystage triple-negative breast cancer
Google Scholar   
Citation:
Meeting Instance:
SABCS 2025
Year:
2025
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
4841  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Genentech  
Grants:
P50-CA058223  
Corr. Author:
 
Authors:
                                                 
Networks:
CA043, LAPS-CT018, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, LAPS-OH007, LAPS-PA015, PA125, RI005, SCOR   
Study
CALGB-40603
Multiple Studies, or Legacy Studies in Alliance Study:
AFT-04
Phases:
2, 3
Keywords: